Marjolein Geurts

1.8k total citations · 1 hit paper
51 papers, 1.0k citations indexed

About

Marjolein Geurts is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Marjolein Geurts has authored 51 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 14 papers in Pulmonary and Respiratory Medicine and 12 papers in Neurology. Recurrent topics in Marjolein Geurts's work include Glioma Diagnosis and Treatment (24 papers), Brain Metastases and Treatment (9 papers) and Traumatic Brain Injury and Neurovascular Disturbances (7 papers). Marjolein Geurts is often cited by papers focused on Glioma Diagnosis and Treatment (24 papers), Brain Metastases and Treatment (9 papers) and Traumatic Brain Injury and Neurovascular Disturbances (7 papers). Marjolein Geurts collaborates with scholars based in Netherlands, United States and Germany. Marjolein Geurts's co-authors include Martin J. van den Bent, Pim J. French, H. Bart van der Worp, Malcolm Macleod, L. Jaap Kappelle, Philip H. C. Kremer, Rainer Kollmar, David Capper, Marion Smits and Jacoline E. C. Bromberg and has published in prestigious journals such as The Lancet, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Marjolein Geurts

47 papers receiving 1.0k citations

Hit Papers

Primary brain tumours in adults 2023 2026 2024 2025 2023 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Primary brain tumours in adults
    2023 157 citations Martin J. van den Bent, Marjolein Geurts et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marjolein Geurts Netherlands 17 268 233 217 190 166 51 1.0k
Kai Shu China 18 190 0.7× 259 1.1× 265 1.2× 154 0.8× 50 0.3× 100 1.0k
Marie‐Claire Y. de Wit Netherlands 26 304 1.1× 420 1.8× 406 1.9× 217 1.1× 19 0.1× 69 1.9k
France W. Fung United States 13 218 0.8× 156 0.7× 51 0.2× 37 0.2× 82 0.5× 32 700
Preethi Ramachandran United States 13 60 0.2× 514 2.2× 72 0.3× 40 0.2× 65 0.4× 50 1.1k
Christina Chen United States 21 193 0.7× 343 1.5× 64 0.3× 84 0.4× 17 0.1× 48 1.4k
Benedetta Pettorini United Kingdom 23 616 2.3× 142 0.6× 451 2.1× 299 1.6× 31 0.2× 70 1.5k
P. Dureau France 18 81 0.3× 317 1.4× 57 0.3× 93 0.5× 76 0.5× 73 1.1k
Masashi Kishi Japan 20 28 0.1× 1.3k 5.7× 72 0.3× 69 0.4× 332 2.0× 38 2.3k
William A. Gomes United States 17 89 0.3× 438 1.9× 149 0.7× 111 0.6× 7 0.0× 38 1.4k
Avery S. Walker United States 13 47 0.2× 172 0.7× 34 0.2× 34 0.2× 53 0.3× 27 700

Countries citing papers authored by Marjolein Geurts

Since Specialization
Citations

This map shows the geographic impact of Marjolein Geurts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marjolein Geurts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marjolein Geurts more than expected).

Fields of papers citing papers by Marjolein Geurts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marjolein Geurts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marjolein Geurts. The network helps show where Marjolein Geurts may publish in the future.

Co-authorship network of co-authors of Marjolein Geurts

This figure shows the co-authorship network connecting the top 25 collaborators of Marjolein Geurts. A scholar is included among the top collaborators of Marjolein Geurts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marjolein Geurts. Marjolein Geurts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perreault, Sébastien, Marjolein Geurts, Jasia Mahdi, et al.. (2025). Point/counterpoint: Upfront BRAF inhibition for adult BRAF-mutant high-grade gliomas. Neuro-Oncology. 27(11). 2804–2811.
2.
Hijfte, Levi van, Marjolein Geurts, Iris de Heer, et al.. (2025). Gemistocytic tumor cells programmed for glial scarring characterize T cell confinement in IDH-mutant astrocytoma. Nature Communications. 16(1). 1156–1156. 2 indexed citations
3.
Vries, Juna M. de, Ide Smets, Robert M. Verdijk, et al.. (2025). Clinical impact and safety of brain biopsy in unexplained central nervous system disorders: a real‐world cohort study. Annals of Clinical and Translational Neurology. 12(4). 792–804. 1 indexed citations
4.
Geurts, Marjolein, Franz Koenig, Burt Nabors, et al.. (2025). Temozolomide chemotherapy for patients with newly diagnosed glioblastoma in the CENTRIC EORTC 26071-22072 and CORE trials: Does time of administration matter?. Neuro-Oncology Practice. 12(2). 291–300. 1 indexed citations
5.
French, Pim J., et al.. (2025). T cell immunity in glioma and potential implications for immunotherapy: A systematic review. Neuro-Oncology. 28(2). 334–352.
6.
Schaff, Lauren, Μαρία Ιωάννου, Marjolein Geurts, et al.. (2024). State of the Art in Low-Grade Glioma Management: Insights From Isocitrate Dehydrogenase and Beyond. American Society of Clinical Oncology Educational Book. 44(3). e431450–e431450. 6 indexed citations
7.
8.
Peters, Katherine B. & Marjolein Geurts. (2024). Practical management of patients with IDH-mutant glioma in the coming era of mIDH inhibitors: New drugs, new evidence, new guidelines, and new considerations. Neuro-Oncology Practice. 12(Supplement_1). i2–i5. 1 indexed citations
9.
Rhun, Émilie Le, Florien Boele, Giuseppe Minniti, et al.. (2023). Gender balance and suitable positive actions to promote gender equality among healthcare professionals in neuro-oncology: The EANO positive action initiative. Neuro-Oncology Practice. 11(1). 46–55. 1 indexed citations
10.
11.
Preusser, Matthias, Marjolein Geurts, Johannes A. Hainfellner, & Martin J. van den Bent. (2023). What is an isocitrate dehydrogenase-mutated central nervous system World Health Organization grade 2 glioma, or who should receive vorasidenib?. Neuro-Oncology. 25(11). 1915–1917. 5 indexed citations
12.
Geurts, Marjolein, et al.. (2021). Quality of dying after acute stroke. European Stroke Journal. 6(3). 268–275. 6 indexed citations
13.
Cui, Tiantian, Erica H. Bell, Joseph McElroy, et al.. (2020). A Novel miR-146a-POU3F2/SMARCA5 Pathway Regulates Stemness and Therapeutic Response in Glioblastoma. Molecular Cancer Research. 19(1). 48–60. 17 indexed citations
14.
Berendsen, Sharon, Wim G.M. Spliet, Marjolein Geurts, et al.. (2019). Epilepsy Associates with Decreased HIF-1α/STAT5b Signaling in Glioblastoma. Cancers. 11(1). 41–41. 14 indexed citations
15.
Ruff, Michael W., Jan C. Buckner, Derek R. Johnson, Martin J. van den Bent, & Marjolein Geurts. (2018). Neuro-Oncology Clinical Debate: PCV or temozolomide in combination with radiation for newly diagnosed high-grade oligodendroglioma. Neuro-Oncology Practice. 6(1). 17–21. 10 indexed citations
16.
Cui, Tiantian, Erica H. Bell, Joseph P. McElroy, et al.. (2018). miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastoma. Oncogene. 38(16). 2923–2936. 47 indexed citations
17.
Geurts, Marjolein, Paul L.M. de Kort, Julia H. van Tuijl, et al.. (2017). Advance directives, proxy opinions, and treatment restrictions in patients with severe stroke. BMC Palliative Care. 16(1). 52–52. 12 indexed citations
18.
Geurts, Marjolein, Malcolm Macleod, Ghislaine J. M. W. van Thiel, et al.. (2014). End-of-life decisions in patients with severe acute brain injury. The Lancet Neurology. 13(5). 515–524. 87 indexed citations
19.
Geurts, Marjolein, Malcolm Macleod, Rainer Kollmar, Philip H. C. Kremer, & H. Bart van der Worp. (2013). Therapeutic Hypothermia and the Risk of Infection. Critical Care Medicine. 42(2). 231–242. 114 indexed citations
20.
Wich, Serge A., et al.. (2003). The status of the Sumatran orang-utan Pongo abelii: an update. Oryx. 37(1). 49–54. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kai Shu Breakdown of academic impact, for papers by Marie‐Claire Y. de Wit Breakdown of academic impact, for papers by France W. Fung Breakdown of academic impact, for papers by Preethi Ramachandran Breakdown of academic impact, for papers by Christina Chen Breakdown of academic impact, for papers by Benedetta Pettorini Breakdown of academic impact, for papers by P. Dureau Breakdown of academic impact, for papers by Masashi Kishi Breakdown of academic impact, for papers by William A. Gomes Breakdown of academic impact, for papers by Avery S. Walker
Rankless by CCL
2026